Pyxis Oncology Inc.

NASDAQ: PYXS · Real-Time Price · USD
1.34
0.10 (8.06%)
At close: Jun 06, 2025, 1:28 PM

Pyxis Oncology Statistics

Share Statistics

Pyxis Oncology has 61.95M shares outstanding. The number of shares has increased by 4.59% in one year.

61.95M
4.59%
3.57%
51.94%
n/a
5,281
1.09%

Short Selling Information

The latest short interest is 7.05M, so 11.38% of the outstanding shares have been sold short.

7.05M
11.38%
13.77%
13.52

Valuation Ratios

The PE ratio is -1.18 and the forward PE ratio is -1.06. Pyxis Oncology's PEG ratio is 0.04.

-1.18
-1.06
5.65
1.1
0.76
-1.57
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pyxis Oncology.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 7.49, with a Debt / Equity ratio of 0.17.

7.49
7.49
0.17
-0.31
-0.35
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$366,954.55
$-1,757,522.73
44
0.1
n/a

Taxes

-2.16M
2.72%

Stock Price Statistics

The stock price has increased by -64.97% in the last 52 weeks. The beta is 1.18, so Pyxis Oncology's price volatility has been higher than the market average.

1.18
-64.97%
1.09
2.12
54.77
486,319

Income Statement

In the last 12 months, Pyxis Oncology had revenue of 16.15M and earned -77.33M in profits. Earnings per share was -1.32.

16.15M
15.67M
-89.46M
-77.33M
-65.51M
-68.5M
-1.32
Full Income Statement

Balance Sheet

The company has 19.47M in cash and 20.2M in debt, giving a net cash position of -727K.

19.47M
20.2M
-727K
-363.56M
135.87M
97.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -57.67M and capital expenditures -237K, giving a free cash flow of -57.91M.

-57.67M
-237K
-57.91M
-0.99
Full Cash Flow Statement

Margins

Gross margin is 97.06%, with operating and profit margins of -554.07% and -478.95%.

97.06%
-554.07%
-492.35%
-478.95%
-405.76%
-554.07%
-358.66%

Dividends & Yields

PYXS does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for PYXS is $9, which is 625.8% higher than the current price. The consensus rating is "Buy".

$9
625.8%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-3.76
1